Svetlana Lucas is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 20,000 shares of JSPR, which is worth approximately $35,400. The most recent transaction as insider was on Sep 22, 2025, when has been sold 20,000 shares (Voting Common Stock) at a price of $2.43 per share, resulting in proceeds of $48,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
n/a 3M change
n/a 12M change
Total Value Held $35,400

Svetlana Lucas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 22 2025
BUY
Open market or private purchase
$48,600 $2.43 p/Share
20,000 Added 50.0%
20,000 Voting Common Stock

Also insider at

LIFE
aTYR PHARMA INC Healthcare
SL

Svetlana Lucas

Director
San Diego, CA

Track Institutional and Insider Activities on JSPR

Follow Jasper Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR